Koordinierungszentrum für Klinische Studien der Philipps-Universität Marburg

Publikationen 2015

Du Bois, A., Reuss, A., Pujade-Lauraine, E., Pignata, S., Ledermann, J., Casado, A., Sehouli, J., Mirza, M., Colombo, N., Marth, C., Witteveen, E., Del Campo, J., Calvert, P., Aravantinos, G., Vardar, M. A., Van Der Zee, A. G., Korach, J., Taskiran, C., Fehr, M., Glasspool, R., Pfisterer, J., Cibula, D. & Vergote, I. 2015. European Network of Gynaecological Oncological Trial Groups' Requirements for Trials Between Academic Groups and Industry Partners-First Update 2015. Int J Gynecol Cancer.

Farthmann, J., Hasenburg, A., Weil, M., Fotopoulou, C., Ewald-Riegler, N., Du Bois, O., Trillsch, F., Mahner, S., Strauss, H. G., Wimberger, P., Reuss, A. & Du Bois, A. 2015. Quality of life and sexual function in patients with borderline tumors of the ovary. A substudy of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) study group ROBOT study. Support Care Cancer, 23(1), 117-23.

Fotopoulou, C., Sehouli, J., Ewald-Riegler, N., De Gregorio, N., Reuss, A., Richter, R., Mahner, S., Kommoss, F., Schmalfeldt, B., Fehm, T., Hanker, L., Wimberger, P., Canzler, U., Pfisterer, J., Kommoss, S., Hauptmann, S. & Du Bois, A. 2015. The Value of Serum CA125 in the Diagnosis of Borderline Tumors of the Ovary: A Subanalysis of the Prospective Multicenter ROBOT Study. Int J Gynecol Cancer.

Mahner, S., Jueckstock, J., Hilpert, F., Neuser, P., Harter, P., De Gregorio, N., Hasenburg, A., Sehouli, J., Habermann, A., Hillemanns, P., Fuerst, S., Strauss, H. G., Baumann, K., Thiel, F., Mustea, A., Meier, W., Du Bois, A., Griebel, L. F. & Woelber, L. 2015. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study. J Natl Cancer Inst, 107(3).

Sehouli, J., Fotopoulou, C., Erol, E., Richter, R., Reuss, A., Mahner, S., Lauraine, E. P., Kristensen, G., Herrstedt, J., Du Bois, A. & Pfisterer, J. 2015. Alopecia as surrogate marker for chemotherapy response in patients with primary epithelial ovarian cancer: a metaanalysis of four prospective randomised phase III trials with 5114 patients. Eur J Cancer, 51(7), 825-32.

Stamelou, M., Pilatus, U., Reuss, A., Respondek, G., Knake, S., Oertel, W. H. & Hoglinger, G. U. 2015. Brain energy metabolism in early MSA-P: A phosphorus and proton magnetic resonance spectroscopy study. Parkinsonism Relat Disord, 21(5), 533-5.

Trillsch, F., Mahner, S., Vettorazzi, E., Woelber, L., Reuss, A., Baumann, K., Keyver-Paik, M. D., Canzler, U., Wollschlaeger, K., Forner, D., Pfisterer, J., Schroeder, W., Muenstedt, K., Richter, B., Fotopoulou, C., Schmalfeldt, B., Burges, A., Ewald-Riegler, N., De Gregorio, N., Hilpert, F., Fehm, T., Meier, W., Hillemanns, P., Hanker, L., Hasenburg, A., Strauss, H. G., Hellriegel, M., Wimberger, P., Kommoss, S., Kommoss, F., Hauptmann, S. & Du Bois, A. 2015. Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT study. Br J Cancer, 112(4), 660-6.

Thomas M, Fischer J, Andreas S, Kortsik C, Grah C, Serke M, von Eiff M, Witt C, Kollmeier J, Müller E, Schenk M, Schröder M, Villalobos M, Reinmuth N, Penzel R, Schnabel P, Acker T, Reuss A, Wolf M; ABC-Lung Cancer Group. Erlotinib and bevacizumab versus cisplatin, gemcitabine and bevacizumab in unselected nonsquamous nonsmall cell lung cancer.
Eur Respir J. 2015 Jul;46(1):219-29.

Poveda AM, Selle F, Hilpert F, Reuss A, Savarese A, Vergote I, Witteveen P, Bamias A, Scotto N, Mitchell L, Pujade-Lauraine E. Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial
J Clin Oncol. 2015 Nov 10;33(32):3836-8.